Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 39, 2022 - Issue 7
Submit an article Journal homepage
171
Views
2
CrossRef citations to date
0
Altmetric
Reports

Vincristine-induced neurotoxicity in pediatric patients with rhabdomyosarcoma: A retrospective analysis of clinical features and outcome

Lama Dakika Faculty of Medicine, American University of Beirut, Beirut, Lebanon
,
Maya Basbousb Department of Pediatrics, Children’s Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon
,
Hani Tamimc Clinical Research Institute, American University of Beirut Faculty of Medicine, Beirut, LebanonORCID Iconhttps://orcid.org/0000-0002-2019-4362
ORCID Icon,
Yacoub Moubarakb Department of Pediatrics, Children’s Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon
,
Nidale Tarekb Department of Pediatrics, Children’s Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon
,
Dima Hamidehb Department of Pediatrics, Children’s Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon
,
Samar Muwakkitb Department of Pediatrics, Children’s Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon
,
Miguel Abboudb Department of Pediatrics, Children’s Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon
&
Raya Saabb Department of Pediatrics, Children’s Cancer Institute, American University of Beirut Medical Center, Beirut, LebanonCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5776-2303
ORCID Icon show all
Pages 644-649 | Received 26 Jul 2021, Accepted 24 Feb 2022, Published online: 09 Mar 2022

References

  • Mora E, Smith EM, Donohoe C, Hertz DL. Vincristine-induced peripheral neuropathy in pediatric cancer patients. Am J Cancer Res. 2016;6(11):2416–2430.
  • Madsen ML, Due H, Ejskjaer N, Jensen P, Madsen J, Dybkaer K. Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review. Cancer Chemother Pharmacol. 2019;84(3):471–485. doi:10.1007/s00280-019-03884-5.
  • Skapek SX, Ferrari A, Gupta AA, et al. Rhabdomyosarcoma. Nat Rev Dis Primers. 2019;5(1):1. doi:10.1038/s41572-018-0051-2.
  • Walterhouse DO, Pappo AS, Meza JL, et al. Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. J Clin Oncol. 2014;32(31):3547–3552. doi:10.1200/JCO.2014.55.6787.
  • Raney RB, Walterhouse DO, Meza JL, et al. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. J Clin Oncol. 2011;29(10):1312–1318. doi:10.1200/JCO.2010.30.4469.
  • Arndt CA, Stoner JA, Hawkins DS, et al. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children’s oncology group study D9803. J Clin Oncol. 2009;27(31):5182–5188. doi:10.1200/JCO.2009.22.3768.
  • Pappo AS, Lyden E, Breitfeld P, et al. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children’s Oncology Group. J Clin Oncol. 2007;25(4):362–369. doi:10.1200/JCO.2006.07.1720.
  • Weigel BJ, Lyden E, Anderson JR, et al. Intensive multiagent therapy, including dose-compressed cycles of ifosfamide/etoposide and vincristine/doxorubicin/cyclophosphamide, irinotecan, and radiation, in patients with high-risk rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol. 2016;34(2):117–122. doi:10.1200/JCO.2015.63.4048.
  • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457–481. doi:10.1080/01621459.1958.10501452.
  • Gupta AA, Anderson JR, Pappo AS, Spunt SL, et al. Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. Cancer. 2012;118(4):1130–1137. doi:10.1002/cncr.26358.
  • Altaf S, Enders F, Lyden E, Donaldson SS, Rodeberg D, Arndt C. Age-related toxicity in patients with rhabdomyosarcoma: a report from the Children’s Oncology Group. J Pediatr Hematol Oncol. 2014;36(8):599–604. doi:10.1097/MPH.0000000000000192.
  • Langholz B, Skolnik JM, Barrett JS, et al. Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children’s Oncology Group. Pediatr Blood Cancer. 2011;57(2):252–257. doi:10.1002/pbc.22882.
  • Kayilioğlu H, Kocak U, Kan Karaer D, et al. Association of CYP3A5 expression and vincristine neurotoxicity in pediatric malignancies in Turkish population. J Pediatr Hematol Oncol. 2017;39(6):458–462. doi:10.1097/MPH.0000000000000910.
  • Gilchrist LS, Tanner LR, Ness KK. Short-term recovery of chemotherapy-induced peripheral neuropathy after treatment for pediatric non-CNS cancer. Pediatr Blood Cancer. 2017;64(1):180–187. doi:10.1002/pbc.26204.
  • Gomber S, Dewan P, Chhonker D. Vincristine induced neurotoxicity in cancer patients. Indian J Pediatr. 2010;77(1):97–100. doi:10.1007/s12098-009-0254-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.